Corona or influenza - quick answer with ViroQ SARS-FluA/B-RSV

BAG Diagnostics GmbH
Products
Infectiology
SARS-FluA/B-RSV RT PCR Diagnostics

SARS-COV-2 Flu A/B RSV real-time PCR detection

ViroQ® SARS-FluA/B-RSV

Coronavirus or influenza? Certainty for flu symptoms in just one PCR run with ViroQ^® SARS-FluA/B-RSV! Our highly specific and innovative detection of SARS-CoV-2, Influenza A/B and RSV delivers reliable results easily and quickly. Get results in as little as 60 minutes with our ready-to-use standard reagents.

Easy: One-step real-time PCR assay
Fast: Results in about 60 minutes
Flexible: works with common RNA isolation kits – independent of individual suppliers
Safe: includes cell material check in the sample material
Available: Quality made in Germany – high security in the supply chain

ViroQ^® SARS-FluA/B-RSV is designed for use on commercially available real-time cyclers.

safe and efficient

TEST-KITS
WORKFLOW
ACCESSORIES
DOWNLOADS
FAQ

Product

Bundle

REF

Certification

Compatibility

ViroQ® SARS-FluA/B-RSV

96 tests

728267

Cycler Compatibility Check

ViroQ® SARS-FluA/B-RSV

480 tests

728268

Cycler Compatibility Check

CFX-CYCLER

We have geared our testing entirely to your needs: Simple and fast! Get results in just over 60 minutes with our ready-to-use standard reagents. The one-step PCR run (incl. reverse transcription) in the real-time cycler delivers rapid results. In addition, the cell material check reliably ensures negative results.

The PCR kit uses five colours that are compatible with most common real-time cyclers. We have carried out tests on QuantStudio 6 (Thermo Fisher Scientific), CFX 96TM (Bio-Rad) and Lightcycler^® 480 (Roche). The evaluation is done via the hardware manufacturer's software.

Instructions for Use

ViroQ SARS-FluA/B-RSV RUO V1/2020 305.91 KB2021-12-13

ViroQ SARS-FluA/B-RSV V2/2021 320.55 KB2021-11-29

ViroQ SARS-FluA/B-RSV V4/2022 291.51 KB2022-03-02

ViroQ SARS-FluA/B-RSV V4/2022 291.56 KB2022-03-02

ViroQ SARS-FluA/B-RSV V2/2021 313.37 KB2021-11-29

ViroQ SARS-FluA/B-RSV V1/2020 364.71 KB2021-11-29

ViroQ SARS-FluA/B-RSV V1/2020 256.82 KB2021-11-29

ViroQ SARS-FluA/B-RSV V3/2021 348.17 KB2021-11-29

ViroQ SARS-FluA/B-RSV RUO V1/2020 305.60 KB2021-12-13

ViroQ SARS-FluA/B-RSV V1/2020 263.93 KB2021-11-29

ViroQ SARS-FluA/B-RSV V3/2021 369.89 KB2021-11-29

MSDS

MSDS-ViroQ-Enzyme-2020-12-DE.pdf 143.69 KB2021-11-29

Erklärung ViroQ Mix und Kontrollen 438.50 KB2021-12-12

MSDS-ViroQ-Solvent-2020-12-EN.pdf 185.41 KB2021-11-29

MSDS-ViroQ-Solvent-2020-12-DE.pdf 184.78 KB2021-11-29

MSDS-ViroQ-Enzyme-2020-12-EN.pdf 171.18 KB2021-11-29

No FAQs created for this product yet! Would you like to create a FAQ suggestion? contact@bag-diagnostics.com

One kit for four test results and more throughput

The symptoms of your patients do not provide any information about the causative pathogens. In addition to SARS-CoV-2, influenza A viruses can also cause widespread influenza waves – up to and including continent-spanning pandemics with severe to life-threatening courses of disease. Even influenza B viruses sometimes cause moderately severe illnesses. A rapid diagnosis of the corresponding virus strain facilitates the appropriate treatment of the symptoms that occur.

With ViroQ^® SARS-FluA/B-RSV, we have therefore developed an innovative test kit that in a single test run

SARS-CoV-2 (also variants)
Influenza A
Influenza B
RSV

is detected in the sample material taken.

YOUR BENEFITS

four tests in one kit for the detection of SARS-CoV-2, Influenza A/B or RS viruses
time-saving thanks to one-step real-time PCR procedure
you get your result in just over 60 minutes
sample quality control – no false negative results
safe handling, ready-to-use reagents
low logistics costs, transport ViroQ^® uncooled

Benedikt Hampen

Product Manager

HLA Diagnostic & Infectiology

+49 6404 925-412

+49 1517 2833148

Drop me a line!

The influenza situation has changed considerably with Coronavirus. ViroQ^® SARS-FluA/B-RSV provides rapid analysis of test swabs in just one PCR run. This helps to initiate the right treatment and reliably localise SARS-CoV-2 disease. Important laboratory resources are thus optimally used.

Swab specimen extraction correct – test result reliable

A correct nasal/pharyngeal swab is essential for a meaningful result. While blood impurities affect performance, inadequate swabs sometimes contain too little cellular material. The ViroQ^® SARS-FluA/B-RSV kit rules out "false negative test results" resulting from this: In the test, the detection of a human, universally occurring gene in cells shows whether sufficient cell material is available for valid results.

One-step real-time PCR

Our test kit is designed for the specific detection of the viral RNA genes N and RdRP of SARS-CoV-2 as well as influenza A/B or RS viruses from throat/nasal swabs. In our test kits the RNA is converted into cDNA in a one-step PCR procedure. This cDNA is amplified in the same real-time PCR protocol.

The kit includes the following components:

1. tube	Mastermix: transcription + amplification
2. tube	Reconstitution buffer for lyophilised mastermix
3. tube	Primer-Probe Mixture: Colour 1: SARS-CoV-2 (FAM) Colour 2: Influenza A (HEX) Colour 3: Influenza B (CY5) Colour 4: RSV (CFR610)
4. tube	Primer-probe mixture: Colour 5: Cell control (Q705) (housekeeping gene)
5. tube	Primer-probe mixture: Colour 5: Cell control (ATTO425) (housekeeping gene)
6. Tube	Primer-probe mixture: Colour 5: Cell control (TAMRA) (housekeeping gene)
7. Tube	Positive Control (SARS-CoV-2-Influenza A/B-RSV Positive Control)